Abstract
Around 10% of all amyotrophic lateral sclerosis (ALS) cases are familial and around 3–5% are fused-in-sarcoma (FUS)-related in Europe. We report a 43-year-old patient with a pathogenic FUS mutation (c.1561C>G p.(Arg521Gly) who presented at our clinic with chorea and subsequently with progressive symptoms of classical ALS. As a result of progressive upper and lower motor neurone deterioration, chorea disappeared and death occurred 2.5 years after the onset of the first manifestations. This first description adds chorea as a possible pleiotropic clinical feature in FUS-related ALS. It further warrants to systematically ask and check for chorea in ALS patients and their relatives.
| Original language | English |
|---|---|
| Pages (from-to) | 309-311 |
| Number of pages | 3 |
| Journal | Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration |
| Volume | 21 |
| Issue number | 3-4 |
| DOIs | |
| Publication status | Published - May 2020 |
Keywords
- Amyotrophic lateral sclerosis
- chorea
- fused-in-sarcoma
Fingerprint
Dive into the research topics of 'Chorea is a pleiotropic clinical feature of mutated fused-in-sarcoma in amyotrophic lateral sclerosis'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver